GenWay Biotech Inc - Company Review
GenWay Biotech Inc - Company ReviewSummary
GenWay Biotech Inc (GenWay), a subsidiary of Aviva Systems Biology Corp is a provider of protein and antibody solutions. The company’s products include proteins, antibodies, ELISA kits, secondary antibodies, reagents, peptides, molecular biology products, active proteins, enzymatic assays and PCR kits. It provides its products for treatment of infectious diseases, cell biology and cancer. GenWay offers services such as protein expression, antibody development, ELISA assay development, clinical laboratory trial services and contract manufacturing services. The company’s clinical laboratory trial services offer pre-clinical study and clinical trial testing to support diagnostic development. GenWay is headquartered in San Diego, California, the US.
This comprehensive company report of GenWay Biotech Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.